Stay updated on BBI503 Combo with Anti-Cancer Agents Clinical Trial

Sign up to get notified when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBI503 Combo with Anti-Cancer Agents Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A notice was added at the top of the page announcing NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T22:25:12.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-17T22:33:25.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T22:19:56.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page. A broad set of drug names, chemical classes, and related MeSH terms were removed from the study's indexed terms (examples include Sunitinib, Paclitaxel, pembrolizumab, Nivolumab, Doxorubicin, and Capecitabine).
    Difference
    21%
    Check dated 2026-09-19T20:46:22.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, representing a new build of the study page.
    Difference
    0.0%
    Check dated 2026-08-29T19:39:55.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.6.4 to v3.6.5, indicating a newer build has been deployed. This is a metadata update and does not change the visible content or user functionality.
    Difference
    0.0%
    Check dated 2026-08-08T10:42:58.000Z thumbnail image

Stay in the know with updates to BBI503 Combo with Anti-Cancer Agents Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.